Sernova Corp
(TSX:SVA)
C$
0.34
-0.015 (-4.23%)
Market Cap: 103.23 Mil
Enterprise Value: 88.31 Mil
PE Ratio: 0
PB Ratio: 26.15
GF Score: 31/100 - Sernova Corp Business Update, Strategy and Outlook Call TranscriptOct 05, 2023
- Sernova Corp Introduction of the New CEO and Recently Appointed Chief Business Officer Call TranscriptSep 22, 2023
- Sernova Corp Cell & Gene Meeting on the Med 2023 TranscriptJun 01, 2023
- Sernova Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Sernova Corp at ROTH Conference TranscriptMar 13, 2023
- Sernova Corp To Discuss on Regenerative Therapeutics to Develop Functional Cures TranscriptOct 11, 2022
- Sernova Corp at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Evotec SE and Sernova Corp to Discuss Exclusive Strategic Partnership M&A Call TranscriptMay 17, 2022
- Sernova Corp CEO Roadshow TranscriptDec 10, 2020
- Sernova Corp At TSX Life Sciences Investor Day TranscriptOct 30, 2020
- Sernova Corp at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 13, 2020
- Sernova Corp At ADA Scientific Sessions TranscriptJun 13, 2020
- Sernova Corp At CEO Conference Call TranscriptMay 29, 2020
Sernova Corp CEO Roadshow Transcript
Dec 10, 2020 / NTS GMT
Release Date Price:
C$0.365
(+17.74%)
Mike Elliott
CEO Roadshow Media, Inc. - Moderator
Hi, I'm Mike Elliott, and you're watching CEO Roadshow. Today, we're joined by Dr. Philip Toleikis, President, and CEO of Sernova, a clinical-stage regenerative medicine company. Their stock trades on the TSX-V under SVA and on the OTCQB under SEOVF and also the FSE under PSH. So, those tickers are printed across the bottom of your screen, so refer to those if you want to look them up.
Questions & Answers
Mike Elliott
CEO Roadshow Media, Inc. - Moderator
Good afternoon, Dr. Toleikis, and welcome to the show.
Dr. Philip Toleikis
Sernova Corp. - President, CEO
Good afternoon, and very pleased to be here.
Mike Elliott
CEO Roadshow Media, Inc. - Moderator
So to start off, what is Sernova's technology and how can it become a functional cure for people with chronic diseases?
Dr. Philip Toleikis
Sernova Corp. - President, CEO
As you know, this is a regenerative medicine
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)